Cellulose membranes suppress complement activation in patients after hemodialysis

American Journal of Kidney Diseases

Volumn 38, Issue 2, 2001, Pages 384-389

  De Water, Ruud ^a   Leenen, Pieter J M ^a   Noordermeer, Cindy ^a   Nigg, Alex L ^a   Houtsmuller, Adriaan B ^a   Kok, Dirk J ^a   Schroumlder, Fritz H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

C3 conversion; Cellulose membrane; Complement activation; Factor H; Hemodialysis (HD); SP 40,40

Indexed keywords

CELLULOSE; COMPLEMENT; COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN G; INULIN; MACROGOL; POLYACRYLONITRILE;

ADULT; ARTICLE; BIOCOMPATIBILITY; BIOMEDICAL ENGINEERING; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DIALYSIS MEMBRANE; HUMAN; IMMUNOGENICITY; IMMUNOMODULATION; KIDNEY FAILURE;

EID: 0034902845     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.26106     Document Type: Article

References (25)

1. Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes
2. Anaphylatoxin formation during hemodialysis: Effects of different dialyzer membranes
3. Complement (C5a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia
4. Biocompatibility of dialysis membranes: Effects on chronic complement activation
5. Clinical implications of hemodialysis membrane biocompatibility
6. Bioincompatibility - Perspectives in 1993
7. Platelet adhesion, contact phase coagulation activation, and C5a generation of polyethylene glycol acid-grafted high flux cellulosic membrane with varieties of grafting amounts
8. Clinical effects of a polyethylene glycol grafted cellulose membrane on thrombogenicity and biocompatibility during hemodialysis
9. Detection of complement activation by counterimmunoelectrophoresis (CIE)
10. Sandwich ELISA assay for quantitative measurement of SP-40,40 in seminal plasma and serum
11. desarg
12. C5b-9 generation and cytokine production in hemodialyzed patients
13. Cuprammonium membranes stimulate interleukin 1 release and arachidonic acid metabolism in monocytes in the absence of complement
14. Cytokines and biocompatibility
15. Blood-membrane interaction in hemodialysis leads to increased cytokine production
16. Effect of the dialysis membrane in the treatment of patients with acute renal failure
17. Biocompatible membranes in acute renal failure: Prospective case-controlled study
18. Hemodialysis-membrane biocompatibility and mortality of patients with dialysis-dependent acute renal failure: A prospective randomized multicentre trial
19. Assembly of terminal SC5b-9 complement complexes: A new index of blood-membrane interaction
20. Fluid phase generation of terminal complement complex as a novel index of bioincompatibility
21. SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis
22. Control of the amplification convertase of complement by the plasma protein beta 1H
23. Apolipoprotein J: Structure and tissue distribution
24. Control of complement system